Trident Texofab (BOM:540726) ROCE % : 16.44% (As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Trident Texofab ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Trident Texofab's annualized ROCE % for the quarter that ended in Dec. 2023 was 16.44%.

Trident Texofab ROCE % Historical Data

The historical data trend for Trident Texofab's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Trident Texofab ROCE % Chart

Trident Texofab Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

ROCE %

Get a 7-Day Free Trial

14.99

18.02

11.54

10.48

15.93

Trident Texofab Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROCE %	Get a 7-Day Free Trial															24.48	9.26	7.37	19.41	16.44

Trident Texofab ROCE % Calculation

Trident Texofab's annualized ROCE % for the fiscal year that ended in Mar. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Mar. 2023 )		(A: Mar. 2022 )		(A: Mar. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Mar. 2023 )		(A: Mar. 2022 )		(A: Mar. 2023 )
	=	64.374	/	( ( (709.881 - 302.488)	+	(773.072 - 372.345) )	/ 2 )
	=	64.374	/	( (407.393	+	400.727)	/ 2 )
	=	64.374	/	404.06
	=	15.93 %

Trident Texofab's ROCE % of for the quarter that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Dec. 2023 )		(Q: Sep. 2023 )		(Q: Dec. 2023 )
	=	63.708	/	( ( (843.932 - 456.476)	+	(0 - 0) )	/ 1 )
	=	63.708	/	( ( 387.456	+	0 )	/ 1 )
	=	63.708	/	387.456
	=	16.44 %

(1) Note: The EBIT data used here is four times the quarterly (Dec. 2023) EBIT data.

Trident Texofab (BOM:540726) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Trident Texofab ROCE % Related Terms

Thank you for viewing the detailed overview of Trident Texofab's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Trident Texofab (BOM:540726) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Manufacturing - Apparel & Accessories » Trident Texofab Ltd (BOM:540726) » Definitions » ROCE %

Traded in Other Exchanges

N/A

Address

Ring Road, Nodh-4/1650, Sahara Darwaja, 2004, 2nd Floor, North Extension, Falsawadi, Begumpura, Surat, GJ, IND, 395003

Website

https://www.tridenttexofab.com

Trident Texofab Ltd is a multi-product fabric trading company. The company is engaged in the business of manufacturing & Wholesale Trading of Textile Fabric Cloth. The company's products offering includes curtains, shower curtains, cushion covers, pillows and Bed sheets. It operates through the Textile Fabric Cloth segment.

Trident Texofab (BOM:540726) Headlines

No Headlines